Methods
A total of 193 patients with severe AS and low EF <40% who were referred to participate in the clinical trial of transcatheter aortic valve implantation (TAVI) were studied. Patients were divided into two groups: group I with low mean transvalvular gradient <40 mmHg ( N =103) and group II with high transvalvular gradients ≥40 mmHg ( N =90). Clinical, hemodynamic and follow-up mortality data were collected.
Methods
A total of 193 patients with severe AS and low EF <40% who were referred to participate in the clinical trial of transcatheter aortic valve implantation (TAVI) were studied. Patients were divided into two groups: group I with low mean transvalvular gradient <40 mmHg ( N =103) and group II with high transvalvular gradients ≥40 mmHg ( N =90). Clinical, hemodynamic and follow-up mortality data were collected.